Recombinant multi-species PRSS2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PRSS2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene belongs to the trypsin family of serine proteases and encodes anionic trypsinogen. It is part of a cluster of trypsinogen genes that are located within the T cell receptor beta locus. Enzymes of this family cleave peptide bonds that follow lysine or arginine residues. This protein is found at high levels in pancreatic juice and its upregulation is a characteristic feature of pancreatitis. This protein has also been found to activate pro-urokinase in ovarian tumors, suggesting a function in tumor invasion. In addition, this enzyme is able to cleave across the type II collagen triple helix in rheumatoid arthritis synovitis tissue, potentially participating in the degradation of type II collagen-rich cartilage matrix. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Jan 2015]
The Alternative Names of target: Anionic trypsinogen,PRSS2,Serine protease 2,TRY2,TRY8,TRYP2,TRYP8,Trypsin II,Trypsin-2,try10
Go
to PRSS2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE1211-Ag-1/ GM-Tg-hg-SE1211-Ag-2 | Human PRSS2 protein | Human |
| GM-Tg-rg-SE1211-Ag-1/ GM-Tg-rg-SE1211-Ag-2 | Rat PRSS2 protein | Rat |
| GM-Tg-mg-SE1211-Ag-1/ GM-Tg-mg-SE1211-Ag-2 | Mouse PRSS2 protein | Mouse |
| GM-Tg-cynog-SE1211-Ag-1/ GM-Tg-cynog-SE1211-Ag-2 | Cynomolgus/Rhesus macaque PRSS2 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE1211-Ag-1/ GM-Tg-felg-SE1211-Ag-2 | Feline PRSS2 protein | Feline |
| GM-Tg-cang-SE1211-Ag-1/ GM-Tg-cang-SE1211-Ag-2 | Canine PRSS2 protein | Canine |
| GM-Tg-bovg-SE1211-Ag-1/ GM-Tg-bovg-SE1211-Ag-2 | Bovine PRSS2 protein | Bovine |
| GM-Tg-equg-SE1211-Ag-1/ GM-Tg-equg-SE1211-Ag-2 | Equine PRSS2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE1211-Ag-1/ GM-Tg-hg-SE1211-Ag-2;
GM-Tg-rg-SE1211-Ag-1/ GM-Tg-rg-SE1211-Ag-2;
GM-Tg-mg-SE1211-Ag-1/ GM-Tg-mg-SE1211-Ag-2; GM-Tg-cynog-SE1211-Ag-1/ GM-Tg-cynog-SE1211-Ag-2; GM-Tg-felg-SE1211-Ag-1/ GM-Tg-felg-SE1211-Ag-2; GM-Tg-cang-SE1211-Ag-1/ GM-Tg-cang-SE1211-Ag-2; GM-Tg-bovg-SE1211-Ag-1/ GM-Tg-bovg-SE1211-Ag-2; GM-Tg-equg-SE1211-Ag-1/ GM-Tg-equg-SE1211-Ag-2 |
| Products Name | PRSS2 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | PRSS2 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PRSS2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.